Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

In the comparison between the two immunizers in patients with RA, local reactions and musculoskeletal symptoms were more frequent with ChAdOx1 than with CoronaVac, especially after the first dose. In summary, the AE occurred mainly after the first dose, and were mild, like previous data from others immunizing agents in patients with rheumatoid arthritis. Vaccination did not worsen the degree of disease activity.

Authors

Institutions

Publication Details

Journal
Advances in Rheumatology
Published
2024-08-12
DOI
https://doi.org/10.1186/s42358-024-00397-5
Citations
3
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

Viviane Angelina de Souza, Aline Teixeira de Landa, Laiza Hombre Dias, Erika Biegelmeyer et al.
3 citations
Advances in Rheumatology
SARS-CoV-2 and COVID-19 Research
1.17
article

Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

Viviane Angelina de Souza, Aline Teixeira de Landa, Laiza Hombre Dias, Erika Biegelmeyer, F Pretti, Vanessa Hax, Jozélia Rêgo, Natália Sarzi Sartori, Emília Inoue Sato, Gilda Aparecida Ferreira, Heitor Filipe Surlo, Alexandre Wagner Silva de Souza, Olindo Assis Martins‐Filho, Valderílio Feijó Azevedo, Valéria Valim, Andréa Teixeira‐Carvalho, Vítor Alves Cruz, Carolina Strauss Estevez Gadelha, Cristiane Kayser, Ketty Lysie Libardi Lira Machado, Marcelo Antônio Amaro Pinheiro, Isac Ribeiro Moulaz, Vanessa de Oliveira Magalhães, Lucas Denardi Dória, Luiza Lorenzoni Grillo, Mariana Freitas de Aguiar, Sérgio Henrique Oliveira dos Santos, Gabriel Smith Sobral Vieira, Camila Maria Paiva França Telles, Bárbara Oliveira Souza, Gecilmara Salviato Pileggi, Camila Guimarães, Priscila Dias Cardoso Ribeiro, Laís Pizzol Pasti, Odirlei André Monticielo, Samira Tatiyama Miyamoto, Charlles Heldan de Moura Castro, Mariana de Oliveira Macabú, Maria da Penha Gomes Gouveia, Danielle Cristina Filgueira Alves Batista, José Geraldo Mill, Adriana María Kakehasi, Flávia Maria Matos Melo Campos Peixoto, Ana Paula Neves Burian, Samuel Elias Basualto Dias, Adah Sophia Rodrigues Vieira, Natália Rodrigues Querido Fortes, Natália Seixas de Melo, Sandra Lúcia Euzébio Ribeiro, Rodrigo Poubel Vieira de Rezende, Ana Karla Guedes de Melo, Marina Deorce de Lima, Juliana Bühring, Antônio Luiz Boechat, Filipe Faé, Ricardo Machado Xavier, Edgard Torres dos Reis-Neto, Rejane Maria Rodrigues de Abreu Vieira, Kátia Lino, Nílzio Antônio da Silva, Raquel Lima de Lima, Anna Carolina Faria Moreira Gomes Tavares, Vanessa Peruhype-Magalhães, Laura Aguiar, Tâmara Santos Melo, Rosely Holanda da Silva Sanches, Anna Carolina Simões Moulin, Yasmin Gurtler Pinheiro de Oliveira, Pollyana Vitoria Thomaz da Costa
article en
3 citations

Abstract

In the comparison between the two immunizers in patients with RA, local reactions and musculoskeletal symptoms were more frequent with ChAdOx1 than with CoronaVac, especially after the first dose. In summary, the AE occurred mainly after the first dose, and were mild, like previous data from others immunizing agents in patients with rheumatoid arthritis. Vaccination did not worsen the degree of disease activity.

Advances in RheumatologyVol. 64(1)
Universidade Federal de Juiz de Fora (BR), Universidade Federal de Minas Gerais (BR), Universidade Federal do Rio Grande do Sul (BR), Universidade Federal Fluminense (BR), Universidade Federal da Paraíba (BR), Universidade de Fortaleza (BR), Hospital Geral de Fortaleza (BR), Universidade Federal do Espírito Santo (BR), Universidade Federal do Paraná (BR), Universidade Federal do Amazonas (BR), Universidade Federal de Goiás (BR), Universidade Federal de São Paulo (BR)
Good health and well-being
Openalex Percentile: Top 22%
SARS-CoV-2 and COVID-19 Research
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.